Condition
Idiopathic Sudden Sensorineural Hearing Loss
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Early P 1 (1)
Trial Status
Unknown2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07045883Not ApplicableActive Not RecruitingPrimary
Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing Loss
NCT04794842Early Phase 1Unknown
Comparing Topical Tetracaine Drops to Topical Focal Phenol for Local Anesthesia During Intratympanic Steroid Injection
NCT02483650Unknown
Hyperbaric Oxygen Therapy Registry
Showing all 3 trials